Eisai GmbH

4 clinical trials · Sponsor

Record	Firm	Date
A Study to Evaluate the Effectiveness of Perampanel as Only Add-on Treatment in Participants With Primary or Secondarily Generalized Tonic-clonic Seizures (NCT04202159)	Eisai GmbH	2020-01-21

Every clearance here is in the API, with alerts when new ones post.